Nutritional iron deficiency anemia
Conditions
Interventions
Trial group:Iron Dextran Granules (Dyne Pharmaceuticals)
control group:Ferric Proteinsuccinate Oral Solution
Sponsors
Beijing Children's Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
2 Years to 12 Years
Inclusion criteria
Inclusion criteria: 1. Indications for children: (1) Normal body temperature; (2) Children with iron deficiency anemia caused by malnutrition; (3) The staged treatment has been completed, before the doctor's order is discharged; (4) The informed consent process complies with the regulations, and the legal representative or the child (>=8 years old) signed the informed consent; 2. Healthy volunteers: (1) Normal body temperature; (2) Apparent health.
Exclusion criteria
Exclusion criteria: 1. Those who cannot eat normally or have difficulty swallowing; 2. Self-reported taste dysfunction; 3. Those who are allergic to iron dextran granules, iron protein succinate oral solution or allergic constitution; 4. Patients with peptic ulcer before activity; 5. Those with mental disorders who cannot correctly express their true feelings; 6. Are receiving drug treatment that may have incompatibility with the experimental drug; 7. Have any test children who are not suitable to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| drug palatability;facial expression;subjective assessment;security indicators; | — |
Countries
China
Contacts
Public ContactWang Xiaoling/Peng Xiaoxia
Beijing Children's Hospital, Capital Medical University
Outcome results
None listed